TipRanks
MoonLake Immunotherapeutics (MLTX)
NASDAQ:MLTX
US Market
MLTX
MoonLake Immunotherapeutics
RESEARCH TOOLSreports
Want to see MLTX full AI Analyst Report?

MoonLake Immunotherapeutics (MLTX) Stock News & Sentiment

675 Followers
MoonLake: Buy Rating Reaffirmed as BLA Progress, Strong HS Data Support Unchanged $34 Price Target
Premium
Ratings
MoonLake: Buy Rating Reaffirmed as BLA Progress, Strong HS Data Support Unchanged $34 Price Target
2d ago
MLTX
MoonLake files FDA application for sonelokimab therapy
Premium
Company Announcements
MoonLake files FDA application for sonelokimab therapy
7d ago
8K
MLTX
MoonLake announces positive Phase 3 psoriatic arthritis results
Premium
Company Announcements
MoonLake announces positive Phase 3 psoriatic arthritis results
2M ago
8K
MLTX
MLTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
MLTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
MLTX
Analyst Maintains Buy on MoonLake, Reiterates $45 Price Target on Strong Financing and Sonelokimab Commercial Potential
Premium
Ratings
Analyst Maintains Buy on MoonLake, Reiterates $45 Price Target on Strong Financing and Sonelokimab Commercial Potential
3M ago
MLTX
MoonLake Immunotherapeutics Announces $200 Million Public Offering
Premium
Company Announcements
MoonLake Immunotherapeutics Announces $200 Million Public Offering
3M ago
8K
MLTX
Buy Rating Reaffirmed on Sonelokimab’s Strong HS Data and Regulatory De-Risking; $30 Price Target Maintained
Premium
Ratings
Buy Rating Reaffirmed on Sonelokimab’s Strong HS Data and Regulatory De-Risking; $30 Price Target Maintained
4M ago
MLTX
More MLTX News >

MLTX News on the Web

MoonLake Immunotherapeutics (MLTX) Files BLA for Sonelokimab to Treat Hidradenitis Suppurativa
GuruFocus News
Bullish
Analysts’ Opinions Are Mixed on These Healthcare Stocks: MoonLake Immunotherapeutics (MLTX) and Liquidia Technologies (LQDA)
TipRanks News
Bullish
Analysts Conflicted on These Healthcare Names: Jade Biosciences (JBIO), MoonLake Immunotherapeutics (MLTX) and Quanterix (QTRX)
TipRanks News
Bullish
MoonLake shares drop 11% pre-market after Q2 earnings, Phase 3 trial results
TipRanks News
Neutral
Insider Sell: Santos da Silva Jorge Sells 102,225 Shares of MoonLake Immunotherapeutics (MLTX)
GuruFocus News
Bearish
BIOTECHNOLOGY VALUE FUND L P's Strategic Acquisition in MoonLake Immunotherapeutics
GuruFocus News
Bullish
MoonLake Immunotherapeutics' CFO Sells 39K Shares
The Motley Fool
Bearish
Insider Sell: Santos da Silva Jorge Sells 47,775 Shares of MoonLake Immunotherapeutics (MLTX)
GuruFocus News
Neutral

News Score - Last 7 Days

Very Positive
MLTX
Sector Average
Media Buzz
This Week4 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MLTX’s Media Buzz Sentiment?
4 articles about MLTX were published this week. In an average week, 1 articles are published.
    What is MLTX’s weekly average amount of articles?
    In an average week, 1 articles about MLTX are published.
      What is MLTX’s News Sentiment?
      100% of articles about MLTX were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        REGNRegeneron
        QTTBQ32 Bio
        NVSNovartis
        RHHVFRoche Holding AG
        KRROKorro Bio
        Showing the stocks with the most bullish news sentiment over the past week